1.Relationship between HDL subclasses and TC/HDL-C, TG/HDL-C ratio
Lianqun JIA ; Lantu GOU ; Mingde FU ; Yanhua XU ; Luchuan YANG
Chinese Journal of Pathophysiology 1986;0(01):-
2.2 in serum, the particle size of HDL shifted towards smaller sizes, which indicates that reverse cholesterol transport might be weakened and HDL maturation might be abnormal.
2.Study on Anti-tumor Effects of Vinblastine Hydrophilic Group Modified Cationic Liposomes in Tumor-bearing Mice
Xuetao LI ; Lan CHENG ; Ying JIANG ; Rongping YU ; Lianqun JIA
China Pharmacy 2015;26(31):4339-4341
OBJECTIVE:To study the anti-tumor effects of Vinblastine (VLB) hydrophilic group modified cationic liposomes in tumor-bearing mice. METHODS:Tumor-bearing model were induced by inoculating yellow ascites of S180 ascites tumor mice. Tumor-bearing mice were randomly divided into model group,VLB sulfate injection group,VLB liposomes group,VLB hydrophil-ic group modified liposomes group,VLB cationic liposomes group and VLB hydrophilic group modified cationic liposomes group, i.e. group A,B,C,D,E and F,with 18 mice in each group. Group A was given normal saline intravenously via mice tail,other groups were given VLB 1.5 mg/kg every 2 days for consecutive 5 times. The anti-tumor effects of different VLB preparations were compared,using living conditions,survival time,tumor volume and weight,and tissue pathological section as indexes. RE-SULTS:Compared with group A,B,C,D and E,the mice of group F were more active,and had longer survival time,smaller tumor volume and lighter tumor weight,with statistical significance(P<0.05). The tissue pathological section of mice in group F indicated that coagulation necrosis,disintegration,and dissolution of tumor cell nucleus. CONCLUSIONS:VLB hydrophilic group modified cationic liposomes have obvious anti-tumor effect,which are better than other VLB preparations.
3.Application of hepatic stem cell transplantation to liver disease treatment
Guijuan XU ; Lianqun JIA ; Yunhai WU ; Yingchun YAN ; Yang CHEN
Chinese Journal of Tissue Engineering Research 2010;14(10):1865-1868
BACKGROUND:At present,the problems such as serious shortage of donor liver organs for transplantation,surgical injury,high incidence of surgical complications,as well as the high costs limit the development of liver transplantation,while the hepatic stem cell(HSC)transplantation provides a new pathway for the treatment of end-stage liver disease.OBJECTIVE:To introduce the source and classification of HSCs,research progress and problems of HSC transplantation for treatment of end-stage liver disease,and the clinical application prospects of HSC transplantation.METHODS:Articles were collected from CNKI and Medline database with the keywords of "hepatic stem cells,liver disease,transplantation" in both Chinese and English from 1999 to 2009.Among 87 articles,30 were included according to inclusion and exclusion criteria.Following reading titles and abstracts,original articles,and articles closely related to HSC transplantation with reliable argument and evidence and general analysis were included.Articles of repetitive studies and poor quality were excluded.RESULTS AND CONCLUSION:The HSC can be divided into liver-derived stem cells and non-liver-derived stem cells.Liver-derived stem cells include hepatic oval cells,mature liver cells and small hepatocyte-like progenitor cell.Non-liver-derived stem cells were mainly derived from embryonic stem cells,bone marrow hematopoietic stem cells and pancreatic stem cells.Currently,the research for the treatment of liver disease by HSC is still in its early stages.There are many difficult issues to be studied and solved in the discovery,separation,purification,comprehensive identification,cultivation,directed differentiation as well as clinical trials.However,as a new source of seed cells,HSC can not only replace the damaged tissue but can stimulate the receptor in tissue regeneration.Hence,compared with the clinical liver transplantation and bio-artificial liver,there are very bright future for the treatment of liver diseases by transplating HSC.
4.Relationship of subclasses of serum HDL and Apo A-Ⅰ gene polymorphism in hyperlipidemia
Lianqun JIA ; Huai BAI ; Mingde FU ; Yanhua XU ; Lantu GOU
Chinese Journal of Pathophysiology 1986;0(04):-
AIM: To investigate apolipoprotein A-Ⅰ gene (Apo A-Ⅰ) polymorphism and its relationship with serum HDL subclasses in patients with hyperlipidemia (HL). METHODS: Apo A-Ⅰ genotype was assayed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The subclasses of serum HDL in 118 patients with hyperlipidemia and 109 healthy subjects were determined by two-dimensional gel electrophoresis conjunction with immunodetection method. RESULTS: Both in HL group and the control group, G/G and C/C genotypes were the most frequent at -78 bp and +83 bp of Apo A-Ⅰ gene, respectively. The frequency of rare A allele at -78 bp in HL group was significantly higher than that in control group. In HL group, subjects with G/A mutation had higher serum levels of TG, Apo C-Ⅲ, pre ?_1-HDL and HDL_ 3a , and lower levels of HDL_ 2a and HDL_ 2b compared to the subjects with G/G genotype. CONCLUSION: The G/A transition in the -78 bp position of the Apo A-Ⅰ gene promoter in patients with hyperlipidemia is associated with HDL subclasses. There is a general shift toward smaller sized HDL, which, in turn, indicates that HDL maturation might be abnormal.
5.Fundamental Research on Antiatherosclerotic Effect of Tanshinone ⅡA
Jiahui MA ; Qiuyu ZHAO ; Zuofeng WANG ; Zhong LI ; Liang ZHAO ; Yongming LIU ; Lianqun JIA
Chinese Journal of Information on Traditional Chinese Medicine 2015;(6):131-133
Tanshinone ⅡA is one of the main effective components in Salviae Miltiorrhizae Radix et Rhizoma. It plays a role in the resistance to atherosclerosis by participating in anti-inflammatory in vascular wall, such as the regulating endothelial cell apoptosis and correcting lipid metabolism disorder. This article summarized recent researches of the basic role of tanshinone ⅡA in the resistance to atherosclerosis and provided references for clinical application of antiatherosclerotic effect of tanshinone ⅡA.
6.Correlation between autophagy and polarization of macrophages in atherosclerosis plaque in arteriosclerosis obliterans amputees.
Wenna CHEN ; Shengnan GUO ; Junyan WANG ; Lianqun JIA ; Dayong LI ; Ying TIAN
Acta Pharmaceutica Sinica 2016;51(1):68-74
This study was designed to investigate the correlation between autophagy and polarization of macrophages in atherosclerosis (AS) plaque in arteriosclerosis obliterans amputees. Femoral artery specimens from arteriosclerosis obliterans amputees were performed hematoxylin and eosin (HE) staining, oil red O and immunofluorescence staining to observe the morphology of atherosclerotic plaque, phenotype of macrophages and autophagy in plaque; using real-time quantitative RT-PCR technology to detect the mRNA level of M1 and M2 type markers in arterial tissue; to analyze polarized signal pathway and autophagy protein levels in macrophages by Western blotting. Arterial specimens staining showed obvious lipid deposition and obvious infiltration of amount of foam cells and inflammatory cells. Macrophages were mainly expression M1 type in percentage in fibrous plaque. Although both M1 and M2 macrophages were upregulated in atheromatous plaque, the increase was dominant in M2 type in percentage. The level of autophagy was significantly higher in the atheromatous plaque than that of fibrous plaque. The expression of tumor necrosis factor- α (TNF-α), monocyte chemotactic protein-1 (MCP-1), inducible nitric oxide synthase (iNOS), interleukin-6 (IL-6) and interleukin-12 (IL-12) mRNA was significantly higher in fibrous plaque than that of atheromatous plaque (P < 0.01 or 0.05), and arginase-1 (Arg-1), transforming growth factor-β (TGF-β), CD163 and interleukin-10 (IL-10) mRNA was significantly lower than that in atheromatous plaque (P < 0.01). The levels of p-STAT1 and NF-κB were significantly increased in fibrous plaque (P < 0.01), while p-STAT6 expression was significantly increased in atheromatous plaque (P < 0.01). The level of LC3-II was significantly higher in atheromatous plaque than that in fibrous plaque (P < 0.01). Macrophages in early atherosclerotic plaque were induced to M1 type through p-STAT1/NF-κB pathway and expressed moderate levels of autophagy; while macrophages in advanced plaques were induced to polarization of M2 type through p-STAT6 pathway. M2 macrophages expressed a higher level of autophagy than M1 macrophages.
7.Effects of Fear of Malpractice and Organizational Support on Job Burnout among Doctors
Journal of China Medical University 2018;47(3):264-267
Objective To explore the relationship between fear of malpractice and job burnout and investigate the mediating role of organizational support in order to provide a theoretical basis for improving doctors'mental health. Methods A total of 1 800 doctors were selected from 8 hospitals of 5 cities in Liaoning province from June to July 2015. Questionnaires included those on personal information, fear of malpractice, organizational support, and job burnout. Additionally, the effective response rate was 1 399. The effects of fear of malpractice and organizational support on job burnout was explored using multiple hierarchical regression analysis. Asymptotic and resampling strategies were used to examine the mediating role of psychological capital between fear of malpractice and job burnout. Results Fear of malpractice was positively associated with emotional exhaustion and depersonalization, and organizational support was negatively associated with emotional exhaustion and depersonalization. Organizational support mediated the relationships between fear of malpractice and emotional exhaustion (0. 2, 95%CI: 0. 15-0. 25) and depersonalization (0. 1, 95%CI:0. 07-0. 13). Conclusion Fear of malpractice and organizational support may have an effect on doctors ' job burnout. In addition, organizational support may have a mediating effect on the relationship between fear of malpractice and job burnout.
8.High Expression of KIFC1 in Glioma Correlates with Poor Prognosis
Pengfei XUE ; Juan ZHENG ; Rongrong LI ; Lili YAN ; Zhaohao WANG ; Qingbin JIA ; Lianqun ZHANG ; Xin LI
Journal of Korean Neurosurgical Society 2024;67(3):364-375
Objective:
: Kinesin family member C1 (KIFC1), a non-essential kinesin-like motor protein, has been found to serve a crucial role in supernumerary centrosome clustering and the progression of several human cancer types. However, the role of KIFC1 in glioma has been rarely reported. Thus, the present study aimed to investigate the role of KIFC1 in glioma progression.
Methods:
: Online bioinformatics analysis was performed to determine the association between KIFC1 expression and clinical outcomes in glioma. Immunohistochemical staining was conducted to analyze the expression levels of KIFC1 in glioma and normal brain tissues. Furthermore, KIFC1 expression was knocked in the glioma cell lines, U251 and U87MG, and the functional roles of KIFC1 in cell proliferation, invasion and migration were analyzed using cell multiplication, wound healing and Transwell invasion assays, respectively. The autophagic flux and expression levels matrix metalloproteinase-2 (MMP2) were also determined using imaging flow cytometry, western blotting and a gelation zymography assay.
Results:
: The results revealed that KIFC1 expression levels were significantly upregulated in glioma tissues compared with normal brain tissues, and the expression levels were positively associated with tumor grade. Patients with glioma with low KIFC1 expression levels had a more favorable prognosis compared with patients with high KIFC1 expression levels. In vitro, KIFC1 knockdown not only inhibited the proliferation, migration and invasion of glioma cells, but also increased the autophagic flux and downregulated the expression levels of MMP2.
Conclusion
: Upregulation of KIFC1 expression may promote glioma progression and KIFC1 may serve as a potential prognostic biomarker and possible therapeutic target for glioma.
9.Influences of Ziyin Xifeng Fang on the JAK/STAT signal pathway in the kidney of spontaneously hypertensive rats
Junyan WANG ; Lin ZHANG ; Lianqun JIA ; Wenna CHEN ; Hongwei SUN ; Chuqian SHAO ; Guanlin YANG
Journal of Beijing University of Traditional Chinese Medicine 2016;(1):30-34
Objective To observe the effects of Ziyin Xifeng Fang ( ZYXFF) , a Chinese medicine com-pound formulated by the method of nourishing yin and extinguishing wind, on the blood pressure and renal JAK/STAT signal pathway in the rat model of spontaneously hypertension ( SH) . Methods 40 SH rats were randomly divided into four groups ( n=10 each):model group, low dose of ZYXFF( low-dose) group, high dose of ZYXFF ( high-dose) group and compound apocynum group. Another 10 SKY rats with the same background were included in the control group. The rats of three treatment groups were ad-ministered intragastrically ( i. g. ) proper drugs, and those of control group and model group were i. g. sa-line for consecutive 42 days. The systolic blood pressure ( BP) was measured by using small animal non-invasive blood pressure meter at Day 0, 7, 14, 21, 28, 35 and Day 42. Two hours after i. g. at the last day of medication, all the rats were sacrificed. The serum contents of creatinin ( Cr) , blood urea nitrogen ( BUN) , and uric acid ( UA) were determined. The serum contents of IL-6 and TNF-αwere detected by ELISA assay, and the protein expression of renal p-JAK1 and p-STAT1 were measured by Western blot. Results Compared with control group, BP, Cr, BUN, UA, IL-6 and TNF-α increased significantly in model group, and the all indexes of the rats of the three medication groups decreased remarkably ( P<0. 05 or P<0 . 01 ) , especially the effects of high dose of ZYXFF and compound apocynum were stronger than those of low dose ZYXFF. Compared with control group, in model group rats renal p-JAK1, p-STAT1 protein expression significantly increased ( P<0 . 01 ) . The protein expressions of p-JAK1 and p-STAT1 decreased in the three medication groups compared with the model group ( P <0 . 05 or P <0 . 01 ) . Conclusion The mechanism of ZYXFF lowering blood pressure and attenuating the renal function impairment should be by the way of inhibiting the activation of JAK/STAT signal pathway.
10.Study on the mechanism of Gynostemma pentaphyllum intervention on atherosclerosis based on network pharmacology
Zhidan WANG ; Qun WANG ; Shuang REN ; Gaoxiang CUI ; Jie ZHANG ; Lianqun JIA
International Journal of Traditional Chinese Medicine 2020;42(10):983-990
Objective:To explore the mechanism of Gynostemma pentaphyllum in the treatment of atherosclerosis (AS) based on network pharmacology. Methods:TCMSP was used to analyze the chemical components and targeted effect of Gynostemma pentaphyllum, through the database like OMIM, TTD, drugbank and digsee to predict and screen the targeted effect of AS. The genes corresponding to the target were queried by UniProt database, and then the compound target (gene) network and protein-protein interaction network (PPI) were constructed by using Cytoscape 3.2.1 to screen out the core target. Finally, the function enrichment analysis of Gene Ontology (GO) and the pathway enrichment analysis based on Kyoto Encyclopedia of genes and genomes (KEGG) were carried out by David, and the mechanism of action was studied. Results:The compound-target network consisted of 13 compounds and 150 corresponding targets. The key targets were PGR, NR3C2, NCOA2, PPARG, PTGS1, PTGS2, etc. PPI network contains 131 proteins and 46 core proteins. There are 480 GO item in GO function enrichment analysis, including 403 entries in biological process (BP), 35 entries in cell composition (CC), and 42 entries in molecular function (MF). 25 signaling pathways related to AS were obtained by enrichment and screening of KEGG pathway, involving PI3K-AKT, TNF, HIF-1, MAPK, toll like receptor and other signaling pathways.Conclusions:This paper discussed the mechanism of Gynostemma pentaphyllum in the treatment of AS through network pharmacology, which provides new ideas and methods for further research and exploration of the mechanism of Gynostemma pentaphyllum in the treatment of AS.